Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Transplant Proc ; 41(8): 3148-50, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19857698

RESUMEN

OBJECTIVE: Urinary tract infection (UTI) is among the common infection in simultaneous pancreas-kidney transplantation (SPKT). PATIENTS AND METHODS: The study included 26 adult patients undergoing SPKT between September 2001 and December 2006. All the patients were followed prospectively for UTI during the first 4 weeks after surgery. Urine samples were investigated for bacteriologic cultures. The micro-organisms were identified in accordance with standard bacteriologic procedures. Susceptibility testing was carried out using Clinical and Laboratory Standards Institute (CLSI) procedures. RESULTS: Among 77 urine specimens obtained from all recipients during the first month, there were 30 isolated bacterial strains. The most common were Gram-positive bacteria (53.3%) with predominance of enterococci (75%) associated with high levels of aminoglycoside resistant strains (HLAR; 58.3%) and vancomycin-resistant strains (VRE; 25%). Gram-negative bacteria were detected in 46.7% of positive cultures. CONCLUSIONS: In our study, enterococci predominated as 75% of Gram-positive isolates. The increased proportion of multi-drug-resistant bacteria, which can caused severe UTI in patients after SPKT, may be due to the frequent use of prophylaxis of bacterial infections in patients.


Asunto(s)
Trasplante de Riñón/efectos adversos , Trasplante de Páncreas/efectos adversos , Infecciones Urinarias/epidemiología , Adulto , Antibacterianos/uso terapéutico , Profilaxis Antibiótica , Cadáver , Farmacorresistencia Bacteriana , Femenino , Bacterias Grampositivas/aislamiento & purificación , Humanos , Inmunosupresores/uso terapéutico , Trasplante de Riñón/inmunología , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Trasplante de Páncreas/inmunología , Donantes de Tejidos
2.
Pharmacopsychiatry ; 41(3): 92-9, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18484550

RESUMEN

INTRODUCTION: Memory deficits and sleep disturbances are common clinical features of schizophrenia. Sleep is supposed to promote memory consolidation and the antipsychotic olanzapine is suggested to improve both sleep and memory functions. Therefore we performed a study to analyse the acute effects of olanzapine on distinct sleep parameters and sleep-related memory consolidation in parallel. METHODS: We studied 26 patients with schizophrenia on stable antipsychotic medication with amisulpride (age range 19-44 years). Immediately before polysomnography and the morning after we performed neuropsychological tasks. Before the third night in the sleep laboratory, patients received either olanzapine or a placebo. RESULTS: We found a significant positive association for slow wave sleep and declarative memory performance in schizophrenia at baseline. Additionally, Stage 2 sleep spindle density was positively related to overnight memory consolidation. Olanzapine caused a significant increase in the amount of slow wave sleep in accordance with recent studies, but led also to a significant decrease in sleep spindle density, which had not been described before. Memory performance the next morning was not different between the two groups. DISCUSSION: Since not only slow wave sleep but also sleep spindles are supposed to promote sleep-related memory consolidation, we suggest that a putative positive effect on memory performance by slow wave sleep augmentation is neutralised by the decrease in sleep spindles due to olanzapine.


Asunto(s)
Antipsicóticos/uso terapéutico , Benzodiazepinas/uso terapéutico , Trastornos de la Memoria/tratamiento farmacológico , Trastornos del Sueño-Vigilia/tratamiento farmacológico , Adulto , Femenino , Humanos , Masculino , Trastornos de la Memoria/etiología , Pruebas Neuropsicológicas , Olanzapina , Polisomnografía/métodos , Escalas de Valoración Psiquiátrica , Esquizofrenia/complicaciones , Esquizofrenia/tratamiento farmacológico , Fases del Sueño/efectos de los fármacos , Trastornos del Sueño-Vigilia/etiología , Encuestas y Cuestionarios
3.
Med J Aust ; 174(4): 178-82, 2001 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-11270758

RESUMEN

OBJECTIVES: To describe an epidemic of dengue type 3 that occurred in far north Queensland in 1997-1999 and its influence on the further development of dengue prevention and control strategies. DESIGN: Epidemiological and laboratory investigation of cases, entomological surveys and phylogenetic analysis of dengue virus isolates. MAIN OUTCOME MEASURES: Numbers and characteristics of confirmed cases; Breteau Index (BI; number of containers breeding Aedes aegypti per 100 premises); effect of control measures on mosquito populations; genetic homology of epidemic virus with other dengue virus isolates. RESULTS: The epidemic lasted 70 weeks and comprised 498 confirmed cases in three towns (Cairns, Port Douglas and Mossman); 101 patients (20%) were admitted to hospital. Median interval between symptom onset and notification was seven days (range, 0-53 days), and cumulative duration of viraemia of public health significance was 2,072 days. BIs in affected areas were high, particularly in Mossman (45) and Port Douglas (31). Control measures significantly reduced mosquito populations (assessed as number of ovitraps containing Ae. aegypti eggs and mean number of eggs per trap [P< 0.05 for both]). However, transmission persisted in several foci, in part due to undetected waterfilled containers breeding Ae. aegypti. The epidemic virus belonged to serotype 3; phylogenetic analysis suggested it was imported from Thailand. CONCLUSIONS: The epidemic had greater morbidity than other recent Queensland epidemics of dengue and was harder to control, necessitating substantial revision of the Dengue Fever Management Plan for North Queensland. The epidemic's severity supports the hypothesis that dengue viruses from South East Asia are more virulent than others.


Asunto(s)
Virus del Dengue/aislamiento & purificación , Dengue/epidemiología , Dengue/prevención & control , Brotes de Enfermedades/prevención & control , Aedes/crecimiento & desarrollo , Animales , ADN Viral/aislamiento & purificación , Virus del Dengue/clasificación , Pruebas de Inhibición de Hemaglutinación , Humanos , Insectos Vectores/crecimiento & desarrollo , Control de Mosquitos , Reacción en Cadena de la Polimerasa , Queensland/epidemiología , Encuestas y Cuestionarios
4.
Arch Virol ; 146(12): 2469-79, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11811694

RESUMEN

Of a panel of forty-six anti-dengue 3 monoclonal antibodies (MAbs) only three neutralised infection of BHK cells by dengue 3 virus. Attempts to select neutralisation escape mutants (n.e.m.) with two of these antibodies failed. The n.e.m. population selected in the presence of the third neutralising antibody, 1H9, had a nucleotide change at position 1157 of the E protein gene resulting in a non-conservative amino acid change at E386 for a Lys to an Asn. A dengue 2 n.e.m. was selected with the flavivirus crossreactive IgG monoclonal antibody 4G2, had deduced amino acid changes at E169 (Ser to Pro) and E275 (Gly to Arg). This dengue 2 n.e.m. population produced smaller plaques in BHK cells than the parental virus, decreased fusion activity (FFWI) and had lost the ability to agglutinate gander erythrocyes at pH 6.0 to 6.7.


Asunto(s)
Anticuerpos Monoclonales/inmunología , Antígenos Virales/inmunología , Virus del Dengue/inmunología , Mapeo Epitopo , Epítopos/inmunología , Proteínas del Envoltorio Viral/inmunología , Animales , Anticuerpos Antivirales/inmunología , Línea Celular , Dengue/virología , Virus del Dengue/clasificación , Pruebas de Inhibición de Hemaglutinación , Humanos , Isotipos de Inmunoglobulinas/inmunología , Pruebas de Neutralización
5.
Med J Aust ; 172(12): 597-9, 2000 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-10914106

RESUMEN

In December 1998, a 37-year-old Queensland woman died from a rabies-like illness, 27 months after being bitten by a flying fox (fruit bat). Molecular techniques enabled diagnosis of infection with Australian bat lyssavirus (ABL), the second human case to be recognised and the first to be acquired from a flying fox. It must be assumed that any bat in Australia could transmit ABL; anyone bitten or scratched by a bat should immediately wash the wounds thoroughly with soap and water and promptly seek medical advice.


Asunto(s)
Mordeduras y Picaduras/virología , Quirópteros/virología , Lyssavirus , Infecciones por Rhabdoviridae/epidemiología , Adulto , Animales , Australia/epidemiología , Femenino , Humanos , Infecciones por Rhabdoviridae/diagnóstico , Infecciones por Rhabdoviridae/transmisión
6.
Med J Aust ; 168(5): 221-5, 1998 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-9539900

RESUMEN

OBJECTIVES: To investigate two outbreaks of dengue type 2 in north Queensland, one in the Torres Strait beginning in late 1996, the other in a Cairns suburb in early 1997. DESIGN: Epidemiological investigation of all laboratory-confirmed cases of dengue, entomological investigation of the local environment, and laboratory analysis of the isolated dengue viruses. MAIN OUTCOME MEASURES: Numbers of confirmed and of locally acquired cases; virus serotype; comparison of nucleotide sequences between viruses isolated from the two outbreaks; and Breteau Index (BI = number of containers with larvae of the mosquito vector Aedes aegypti found per 100 houses investigated) on the affected islands and in the Cairns suburb. RESULTS: There were 201 confirmed cases of dengue in the Torres Strait outbreak, which lasted nearly seven months, and seven confirmed cases in the Cairns outbreak, which lasted about nearly 11 weeks. Most (190) were confirmed as dengue type 2. Nucleotide sequencing of viruses isolated from the two outbreaks showed they were identical. Ae. aegypti breeding sites were very common on the five Torres Strait islands surveyed (BIs, 73-219--high risk), but less so in the Cairns suburb (BI, 23). The most common breeding sites were water storage reservoirs, particularly rainwater tanks, on the outer Torres Strait islands, discarded containers (such as plastic containers, buckets and tyres) on Thursday Island, and garden items (such as flowerpot bases and jars) in Cairns. CONCLUSIONS: The virus responsible for the Cairns outbreak was most probably introduced from the Torres Strait, whereas the virus responsible for the Torres Strait outbreak was imported from Papua New Guinea. Preventive strategies tailored to specific locations are needed to reduce breeding of Ae. aegypti in north Queensland, and the consequent risk of future outbreaks of dengue.


Asunto(s)
Virus del Dengue/clasificación , Dengue/epidemiología , Brotes de Enfermedades/estadística & datos numéricos , Dengue Grave/epidemiología , Adolescente , Adulto , Aedes/virología , Anciano , Animales , Secuencia de Bases , Niño , Preescolar , Estudios Transversales , Dengue/transmisión , Dengue/virología , Virus del Dengue/genética , Virus del Dengue/inmunología , Femenino , Humanos , Inmunoglobulina M/sangre , Incidencia , Lactante , Masculino , Persona de Mediana Edad , Queensland/epidemiología , ARN Viral/genética , Dengue Grave/transmisión , Dengue Grave/virología
7.
Ann Ist Super Sanita ; 31(3): 301-5, 1995.
Artículo en Italiano | MEDLINE | ID: mdl-8712572

RESUMEN

Repeated cross-sectional surveys have been conducted to collect information on the trend of HIV prevalence among drug users attending drug treatment centers in Italy in the years 1990-92. Annual HIV prevalence was 31.5% in 1990, 29.1% in 1991, and 24.6% in 1992, showing a declining trend. HIV prevalence was higher in the North than in the South of the country, and among females than in males. Drug users entering treatment for the first time during the study period were less likely to be infected than old clients.


Asunto(s)
Infecciones por VIH/epidemiología , Centros de Tratamiento de Abuso de Sustancias/estadística & datos numéricos , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/terapia , Femenino , Infecciones por VIH/etiología , Seroprevalencia de VIH/tendencias , Humanos , Italia/epidemiología , Masculino , Prevalencia
8.
Eur J Epidemiol ; 9(6): 663-6, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8150071

RESUMEN

Two surveys were conducted in 1990 and 1991 in order to estimate the prevalence of HIV infection among injecting drug users attending drug treatment centers throughout Italy. Among the 35,073 IDUs attending these facilities in 1990, 32.1% were HIV-positive. In 1991, 29.7% of 41,794 IDUs were HIV-positive. HIV prevalence was higher among prior attendees compared to new entrants (38.0% vs. 20.5% in 1990, and 35.8% vs. 16.6% in 1991); prevalence was also higher among females. These findings suggest that HIV prevalence among Italian drug users is slowly declining.


Asunto(s)
Infecciones por VIH/epidemiología , Seroprevalencia de VIH/tendencias , Centros de Tratamiento de Abuso de Sustancias , Abuso de Sustancias por Vía Intravenosa/terapia , Adulto , Femenino , Seropositividad para VIH/epidemiología , Humanos , Italia/epidemiología , Masculino , Oportunidad Relativa , Abuso de Sustancias por Vía Intravenosa/complicaciones
9.
Br J Addict ; 87(12): 1643-8, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1490078

RESUMEN

We used data from different sources to estimate the extent and the trend of the epidemic of drug use in Italy in the second half of the '80s. During the study period, the number of subjects attending drug dependency units increased from 13,905 to 61,689. Mortality and morbidity indicators showed an increase in both drug related deaths (mainly from overdose) and AIDS cases reported in injecting drug users, particularly among older subjects. However, the number of young adults detected as drug users at the army recruitment remained virtually stable from 1986 on. These findings suggest that both demand and availability of treatment increased through the years 1985-89, and that clinical consequences of drug use related behaviour have become an important public health priority.


Asunto(s)
Salud Pública , Trastornos Relacionados con Sustancias/mortalidad , Síndrome de Inmunodeficiencia Adquirida/transmisión , Adolescente , Adulto , Atención a la Salud/organización & administración , Sobredosis de Droga , Femenino , Promoción de la Salud , Heroína/efectos adversos , Humanos , Italia/epidemiología , Masculino , Metadona/uso terapéutico , Persona de Mediana Edad , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Trastornos Relacionados con Sustancias/epidemiología , Encuestas y Cuestionarios
10.
AIDS ; 6(9): 963-9, 1992 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1388909

RESUMEN

OBJECTIVES: To evaluate the use of zidovudine prophylaxis in HIV-exposed health-care workers (HCW) in Italy and to determine its short-term toxicity. DESIGN: Longitudinal, open study with retrospective and prospective collection of data. SETTING: All Italian clinical centres that care for HIV-infected patients and are licensed by the Ministry of Health to dispense zidovudine and 30 hospitals participating in the Italian Multicentre Study on Occupational Risk of HIV Infection. STUDY POPULATION: HCW and other individuals who accepted zidovudine prophylaxis after accidental exposure to HIV. RESULTS: Data were collected for 224 HIV-exposed individuals until 30 June 1991. An increase in zidovudine prophylaxis was observed. All but 10 subjects received 1000-1250 mg zidovudine per day. Anaemia (five cases), neutropenia (one case) and an increase in serum alanine aminotransferase levels (two cases) were the only haematochemical side-effects observed; none of the subjects ceased prophylaxis because of side-effects. More than 50% of subjects had constitutional reactions; as a result, prophylaxis was stopped by 29 patients. These adverse effects began within 10 days of prophylaxis; all resolved after prophylaxis was stopped. No HIV-antibody seroconversions were observed after a mean follow-up of 8 months. CONCLUSIONS: Zidovudine prophylaxis has become a feature of the management of occupational exposures to HIV in health-care settings; short-term toxicity is mild, dose-related and reversible. Further studies are needed to assess the risk of long-term sequelae.


Asunto(s)
Infecciones por VIH/prevención & control , Personal de Salud , Enfermedades Profesionales , Zidovudina/uso terapéutico , Administración Oral , Adolescente , Adulto , Anciano , Anemia/inducido químicamente , Femenino , Estudios de Seguimiento , Infecciones por VIH/epidemiología , Infecciones por VIH/transmisión , Pruebas Hematológicas , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Neutropenia/inducido químicamente , Estudios Prospectivos , Estudios Retrospectivos , Zidovudina/administración & dosificación , Zidovudina/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...